Dermapharm Holding SE Stock

Equities

DMP

DE000A2GS5D8

Pharmaceuticals

Real-time Estimate Tradegate 06:08:17 2024-04-25 am EDT 5-day change 1st Jan Change
31.35 EUR -0.48% Intraday chart for Dermapharm Holding SE -1.57% -26.07%
Sales 2024 * 1.17B 1.25B Sales 2025 * 1.22B 1.31B Capitalization 1.7B 1.82B
Net income 2024 * 112M 120M Net income 2025 * 130M 139M EV / Sales 2024 * 2.15 x
Net Debt 2024 * 812M 869M Net Debt 2025 * 699M 748M EV / Sales 2025 * 1.96 x
P/E ratio 2024 *
15.1 x
P/E ratio 2025 *
13.1 x
Employees 3,497
Yield 2024 *
3.34%
Yield 2025 *
3.82%
Free-Float 32.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.56%
1 week-1.41%
Current month-3.49%
1 month-5.75%
3 months-18.39%
6 months-16.67%
Current year-25.60%
More quotes
1 week
31.30
Extreme 31.3
33.10
1 month
31.00
Extreme 31
34.40
Current year
31.00
Extreme 31
43.22
1 year
31.00
Extreme 31
49.48
3 years
31.00
Extreme 31
91.95
5 years
28.06
Extreme 28.055
91.95
10 years
21.58
Extreme 21.575
91.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 17-07-31
Director of Finance/CFO - 22-10-31
Investor Relations Contact - 18-11-30
Members of the board TitleAgeSince
Director/Board Member 75 17-12-31
Chairman 68 17-07-31
Director/Board Member 63 17-07-31
More insiders
Date Price Change Volume
24-04-25 31.3 -0.63% 7 590
24-04-24 31.5 -3.08% 34,510
24-04-23 32.5 -0.61% 22,522
24-04-22 32.7 +2.51% 32,788
24-04-19 31.9 +0.31% 19,631

Delayed Quote Xetra, April 24, 2024 at 11:35 am EDT

More quotes
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
31.5 EUR
Average target price
56.9 EUR
Spread / Average Target
+80.63%
Consensus